Novo Nordisk and e-therapeutics have opted to extend their drug discovery collaboration launched last December in Type 2 diabetes to incorporate a new approach to genomic data.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,